Senseonics (NYSE:SENS) Shares Gap Up – Still a Buy?

Senseonics Holdings, Inc. (NYSE:SENS)’s share price gapped up prior to trading on Thursday . The stock had previously closed at $1.17, but opened at $1.23. Senseonics shares last traded at $1.29, with a volume of 5,848,861 shares traded.

Analyst Ratings Changes

Several research firms have recently weighed in on SENS. HC Wainwright reaffirmed a “buy” rating and issued a $2.00 price target on shares of Senseonics in a report on Friday, November 15th. StockNews.com started coverage on shares of Senseonics in a research report on Thursday, December 26th. They set a “sell” rating for the company.

Senseonics Stock Down 5.3 %

The firm’s 50-day simple moving average is $0.73 and its 200-day simple moving average is $0.48. The company has a debt-to-equity ratio of 59.17, a quick ratio of 2.38 and a current ratio of 2.47.

Insider Transactions at Senseonics

In other news, CFO Frederick T. Sullivan bought 124,933 shares of the company’s stock in a transaction dated Thursday, December 12th. The stock was bought at an average cost of $0.38 per share, for a total transaction of $47,474.54. Following the completion of the acquisition, the chief financial officer now owns 2,478,844 shares in the company, valued at approximately $941,960.72. This trade represents a 5.31 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Timothy T. Goodnow purchased 315,000 shares of the firm’s stock in a transaction that occurred on Tuesday, December 10th. The stock was bought at an average cost of $0.31 per share, with a total value of $97,650.00. Following the completion of the purchase, the chief executive officer now owns 11,310,355 shares of the company’s stock, valued at $3,506,210.05. This represents a 2.86 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 3.60% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Senseonics

A number of institutional investors have recently bought and sold shares of SENS. Symmetry Partners LLC bought a new position in Senseonics in the third quarter worth about $164,000. GSA Capital Partners LLP bought a new position in shares of Senseonics during the third quarter valued at approximately $117,000. FMR LLC increased its stake in shares of Senseonics by 48,267.2% during the third quarter. FMR LLC now owns 168,318 shares of the company’s stock valued at $59,000 after purchasing an additional 167,970 shares in the last quarter. Geode Capital Management LLC increased its stake in shares of Senseonics by 3.2% during the third quarter. Geode Capital Management LLC now owns 5,838,396 shares of the company’s stock valued at $2,042,000 after purchasing an additional 179,103 shares in the last quarter. Finally, Ridgecrest Wealth Partners LLC purchased a new stake in shares of Senseonics during the fourth quarter valued at approximately $60,000. 12.36% of the stock is owned by institutional investors.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.